1. Guest, the 'News in Brief' for the week beginning 29th May 2023 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Public Chemotherapy-free ‘cancer vaccine’ moves from mice to human trials at Stanford

Discussion in 'Other health news and research' started by Ron, Mar 27, 2018.

  1. Ron

    Ron Established Member (Voting Rights)


    A few excerpts from the article:

    "A recent Stanford cancer study that cured 97 percent of mice from tumors has now moved on to soliciting human volunteers for a new cutting-edge medical trial."

    "The trial is part of a gathering wave of research into immunotherapy, a type of treatment that fights cancer by using the body's immune system to attack tumors."

    "The treatment is not a true vaccine that creates lasting immunity, but it does feature a vaccine-like injection carrying two immune-stimulators that activate the immune system's T cells to eliminate tumors throughout the body."

    "Levy, along with Stanford instructor of medicine Idit Sagiv-Barfi, published their study on the cancer-curing effect of immunotherapy on January 31 in Science Translational Medicine. Levy is a pioneer in the field of cancer immunotherapy having contributed to the development of rituximab, one of the first monoclonal antibodies approved for use as an anti-cancer treatment in humans."
    Solstice, Barry, BurnA and 5 others like this.

Share This Page